9 Meters Announces Initiation of Phase 2 VIBRANT Study of Vurolenatide for Short Bowel Syndrome
Initiating the largest Phase 2 placebo-controlled trial in short bowel syndromeTopline results of the multicenter VIBRANT study anticipated in Q4...
News
SBL Technologies becomes the first distributor of Safe Entry Stations powered by Predictmedix Inc. and JUICEWORKS
Safe Entry Stations, Powered by Predictmedix and Juiceworks Safe Entry Stations (Interior Entry Station) TORONTO, June 14, 2021 (GLOBE NEWSWIRE)...
The Board of Directors of Nexstim Plc resolved on amendments of the stock options 2020 and cancellation of stock options 2016B held by the company and ending option plan 2013A
Company announcement, Helsinki, 14 June 2021 at 4 PM (EEST) The Board of Directors of Nexstim Plc resolved on amendments...
Editas Medicine Strengthens Executive Leadership Team to Advance Pipeline and Support Long-term Growth
Mark Shearman Dr. Mark S. Shearman, Ph.D., joined Editas Medicine today as Executive Vice President and Chief Scientific Officer. Chi...
Nexstim Plc: Decisions of the Board of Directors regarding issuance of shares under the restricted share unit plan and directed share issue
Company announcement, Helsinki, 14 June 2021 at 3:30 PM (EEST) Nexstim Plc: Decisions of the Board of Directors regarding issuance...
Medexus to Present at Raymond James Human Health Innovation Conference
TORONTO, CHICAGO and MONTREAL, June 14, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF)...
Cassava Sciences Announces the Appointment of Richard J. Barry to its Board of Directors
- Mr. Barry To Contribute Additional Board-level Perspective Around Growth, Governance, Sustainability and Societal Goals – AUSTIN, Texas, June 14,...
Cocrystal’s Lead COVID-19 Antiviral CDI-45205 Shown to be Active Against SARS-CoV-2 and Two Prominent SARS-CoV-2 Variants
BOTHELL, Wash., June 14, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology...
AceAge Appoints John Simmons as New CEO
Burlington, Ontario--(Newsfile Corp. - June 14, 2021) - Kym Anthony, AceAge Inc. Board Chair, has confirmed the appointment of John...
CENTR Brands Corp. Signs Distribution Agreement with Hayden Beverage
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2021) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company") today...
Accelmed Expands Senior Team With Two New Partners
Seasoned HealthTech Executive Eric Tansky Joins as General Partner; Experienced Private Equity Professional Stephen Rubin Joins as Partner Also Bolsters...
Mobile Heartbeat Announces Upcoming Launch of Banyan, a Cloud-Based Communication Platform
The First Application on the New Platform Will Be Banyan Voice, a clinical VoIP Solution WALTHAM, Mass.--(BUSINESS WIRE)--Mobile Heartbeat, a...
New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hyperoxemia-Mediated Morbidity During One-Lung Ventilation
Researchers Found That ORi-Guided Thoracic Anesthesia May Reduce Hospital Length of Stay and Increase Patient Safety NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ:...
Core One Labs’ Biosynthesized Psilocybin Provisional Patent Imminent
VANCOUVER, British Columbia, June 12, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN:...
Westlake Hills TX Dental Bonding Cosmetic Dentistry Updated
Westlake Hills Dental Arts has updated cosmetic dental bonding treatents. The practice is showing Rollingwood, Lost Creek, Tarrytown, and Greater...
Cease Trade Order Issued by the Ontario Securities Commission
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH...
Ascendis Pharma A/S Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ hGH (Lonapegsomatropin) for Pediatric Growth Hormone Deficiency
Prescription Drug User Fee Act (PDUFA) goal date extended by three months for further review of submission to September 25,...
COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnson’s Emergency Use Authorization
Emergent continues to work with the FDA to address identified observations at Bayview facility in order to release additional batches...
Nova Leap Health Corp. Closes CAD$5.5 Million Oversubscribed Non-Brokered Private Placement
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER...
Sorrento Receives Authorization From the UK Regulatory Agency to Conduct a Phase 2 Clinical Trial for COVI-DROPS in an Outpatient Setting
Large Phase 2 efficacy trial cleared to start in the United Kingdom in newly diagnosed SARS-CoV-2 infected patients.COVI-DROPS is administered...